The virtual eISICEM (International Symposium on Intensive Care & Emergency Medicine) will take place from 15–18 September 2020.Aerogen are running a symposium on Monday September 7th entitled Inhalation Therapy in Critical Care on Tuesday Sept 15th, 2020 11.00 – 11.45 CET at eISICEM
Join leading critical care experts for a discussion regarding the delivery of inhalation therapy to patients receiving both ventilatory and non-ventilatory support in the era of COVID-19 and how to implement best practices for optimal patient care.
INHALATION THERAPY DURING NON-VENTILATORY SUPPORTProfessor Stephan Ehrmann, MD, PhD
INHALATION THERAPY DURING VENTILATORY SUPPORTProfessor Geoff Bellingan, FRCP, PhD
Register via: https://www.isicem.org/
Connect via: https://live.mymediazone.eu/events/e-ISICEM_W01
About eISICEMISICEM is a non-profit organization, which was created in 1980 around one international symposium and has expanded over the years so that we now run a series of 8 meetings annually, covering different aspects of intensive care and emergency medicine.In 1980, almost 200 attended our first meeting held in a single room and led by just 6 speakers.
In 2019, we welcomed more than 6000 participants to our educational meetings, from 104 countries worldwide!
ISICEM is fully independent – we are not part of a scientific society, so are free to invite the very best leaders and speakers from around the globe without having to abide by specific society principles, rules or quotas.
The aim of ISICEM has always been and remains to improve the care of the critically ill patient through better clinical management, by facilitating ongoing education and training of all healthcare staff involved in patient care and supporting and encouraging constructive research in the field. Our hope is that every person who attends one of our events will learn something new and useful that they can take back to their units and share with colleagues to improve the practice of intensive care and ultimately patient outcomes.
About AerogenFounded in Galway, Ireland in 1997, Aerogen now employs over 200 people worldwide and its products have benefited over 10 million patients. The company, synonymous with scientific excellence, and with a wealth of international awards, has a strong international presence with offices in Ireland, UK, Germany, United States, Middle East, Asia and most recently India.
Aerogen specialises in the design, manufacture and commercialisation of aerosol drug delivery systems. Aerogen’s patented vibrating mesh technology turns liquid medication into a fine particle mist, gently and effectively delivering drugs to the lungs of patients, enhancing outcomes and giving healthcare professionals a higher level of confidence and control.